GTP
TEVA icon

Global Thematic Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Global Thematic Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-830,820
Closed -$43.6M – 83
2014
Q2 		$43.6M Sell
830,820
-452,537
-35% -$23.1M 0.67% 46
2014
Q1 		$67.8M Sell
1,283,357
-1,614,514
-56% -$74.6M 1.1% 34
2013
Q4 		$116M Buy
+2,897,871
New +$114M 1.8% 19

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Global Thematic Partners's TEVA Position: Q3 2014 in Review

Global Thematic Partners sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 830,820 shares — an estimated $43.6M sold.

Global Thematic Partners first reported a position in TEVA in Q4 2013 and held it in 3 quarters. The position peaked at $116M in Q4 2013. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • Global Thematic Partners reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Global Thematic Partners sold 830,820 Teva Pharmaceuticals shares in Q3 2014, an estimated $43.6M.
  • Global Thematic Partners first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 3 quarters.
  • Global Thematic Partners's Teva Pharmaceuticals position peaked at $116M in Q4 2013.
  • 773 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Global Thematic Partners's 13F filing for Q3 2014, filed 27 Oct 2014.